Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.30 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.30 |
| ▸ | LTK | P29376 | 1/20 | 0.30 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.30 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.30 |
| ▸ | CDK8 | P49336 | 1/20 | 0.30 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.30 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.30 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.30 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.30 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.30 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30733631 | 1.00 | HTR6 (0.54) | HTR6KCNH2MAOACHEK1DAPK3 | |
| SCHEMBL29849641 | 0.83 | HTR6 (0.51) | HTR6 | |
| SCHEMBL1436947 | 0.83 | HTR6 (0.51) | HTR6 | |
| SCHEMBL7618202 | 0.82 | HTR6 (0.67) | HTR6KCNH2MAOA | |
| SCHEMBL6130448 | 0.76 | HTR6 (0.74) | HTR6MAOA | |
| SCHEMBL2338975 | 0.74 | HTR6 (0.56) | HTR6MAOA | |
| SCHEMBL31121639 | 0.74 | HTR6 (0.56) | HTR6MAOA | |
| SCHEMBL23160905 | 0.74 | HTR6 (0.53) | HTR6 | |
| SCHEMBL29602604 | 0.74 | HTR6 (0.53) | HTR6 | |
| SCHEMBL4444191 | 0.73 | HTR6 (0.49) | HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3755705-B1 | CATALYSTS, CATALYST SYSTEMS, AND METHODS FOR USING THE SAME | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2024-09-04 | — | — | EP | disclosed |
| US-11440979-B2 | Catalysts, catalyst systems, and methods for using the same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-09-13 | — | — | US | disclosed |
| EP-3755705-A1 | CATALYSTS, CATALYST SYSTEMS, AND METHODS FOR USING THE SAME | ExxonMobil Chemical Patents Inc. (US) | 2020-12-30 | — | — | EP | disclosed |
| US-20200339712-A1 | Catalysts, Catalyst Systems, and Methods for Using the Same | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2020-10-29 | — | — | US | disclosed |
| US-20200339712-A1 | Catalysts, Catalyst Systems, and Methods for Using the Same | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2020-10-29 | — | — | US | disclosed |
| WO-2019160710-A1 | CATALYSTS, CATALYST SYSTEMS, AND METHODS FOR USING THE SAME | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-08-22 | — | — | WO | disclosed |
| WO-2019160710-A1 | CATALYSTS, CATALYST SYSTEMS, AND METHODS FOR USING THE SAME | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-08-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11440979-B2 | Catalysts, catalyst systems, and methods for using the same | CYCS, CAT, PARG | HTR6 3973/4885KCNH2 3976/4885MAOA 326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.